FL118, a Novel Camptothecin Derivative, Is Insensitive to ABCG2 Expression and Shows Improved Efficacy in Comparison With Irinotecan in Colon and Lung Cancer Models With ABCG2-induced Resistance
Molecular Cancer - United Kingdom
doi 10.1186/s12943-015-0362-9
Full Text
Open PDFAbstract
Available in full text
Date
April 28, 2015
Authors
Publisher
Springer Science and Business Media LLC